Aardvark Therapeutics, Inc. Common Stock ( AARD) - Stock Earnings
AARD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -16.3 million USD | — USD |
| 2025Q4 | -17.6 million USD | — USD |
| 2026Q1 | -21.6 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
AARD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -7.2 million USD | — USD |
| 2024 | -20.6 million USD | — USD |
| 2025 | -57.6 million USD | — USD |
| 2026 Est. | — | — |
AARD
Price: $3.93
52 week price:
Earnings Per Share: -3.21 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 80.3 million